NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

ICU Medical, Inc. (ICUI) Stock Analysis

ICU Medical, Inc. (ICUI) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

ICUI

$167.58

+$1.29 (+0.78%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ICUI with… →

ICUI Key Statistics

As of Sep 4, 2026
Trading
Open
$165.30
Previous Close
$166.29
Day's Range
164.80–167.87
52-Week Range
112.50–192.85
Volume
163.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.76
Valuation
Market Cap
$4.19B
P/E Ratio
138.50
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.37
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.08
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.94
EPS (ttm)Profit attributable to each share over the last twelve months.
1.21
Financials (FY)
Revenue (FY)
$2.23B−6.33%
Net Income (FY)
$732.00K
Profit marginThe share of revenue left as profit after all costs and taxes.
1.39%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
25.01M
1-Year Return
+33.39%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
301.32K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ICUI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+17.46%
2025−8.06%
2024+55.57%
2023−36.66%
2022−33.65%
2021+10.65%
2020+14.63%
2019−18.51%
2018+6.31%
2017+46.59%
2016 (partial year)+25.50%

As of September 4, 2026.

ICUI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.23B$732.00K0.0%
2024$2.38B−$117.69M−4.9%
2023$2.26B−$29.66M−1.3%
2022$2.28B−$74.29M−3.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.23B$822.04M$109.33M$732.00K0.0%
2024$2.38B$824.78M$97.41M−$117.69M−4.9%
2023$2.26B$739.87M$47.84M−$29.66M−1.3%
2022$2.28B$697.76M−$3.57M−$74.29M−3.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ICUI Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricICUIMedical Instruments & Supplies medianvs median
P/E138.5035.613.9x the median
P/S ratio1.943.1739% below
Profit margin1.39%0.85%0.5 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values ICU Medical, Inc. (ICUI) at $4.19B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 13,000.

The 52-week range on file runs from $112.50 to $192.85. ICUI last closed at $167.58 on September 4, 2026. That is +$1.29 (+0.78%) against the previous close. The latest close sits 48.96% above that 52-week low.

Financial Health

In fiscal 2025, ICU Medical, Inc. reported revenue of $2.23B. Against the prior fiscal year total of $2.38B, that is a change of −6.33%. The same year closed with net income of $732.00K. The reported profit margin is 1.39%. That is 0.5 percentage points above the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are 1.21.

Across the 4 fiscal years on file, revenue moves from $2.28B in 2022 to $2.23B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 138.5 times earnings. That is 3.9 times the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 17.37. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.08. Measured against sales, the shares trade at 1.94 times revenue. On price-to-sales that is 38.84% below the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Over the trailing twelve months the price has returned +33.39%. Measured over 10 years, that is +2.81% a year compounded. Beta against the wider market is reported at 0.76. Annualized volatility over the trailing 10 years is 37.79%.

Growth & Income

The record shows no dividend for ICUI.

2026 is still running; the price is +17.46% year to date. The strongest complete calendar year on file is 2024 at +55.57%; the weakest is 2023 at −36.66%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

ICU Medical, Inc. (ICUI) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
ICU Medical, Inc. ICUI $4.19B 138.5
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. ICU Medical, Inc. trades at a P/E of 138.5.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Visit website →